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THE FATE OF IRON RELEASED FROM HEME DEGRADATION BY HEME 
OXYGENASE- l 
Jonathan Gardner 
Department of Chemistry and Biochemistry, Utah State University, Logan, Utah 84321 
in conjunction with the Undergraduate Summer Research Award, under the supervision 
of Professor Steven D. Aust, Summer 2005. 
ABSTRACT: A strain of Escherichia coli was genetically modified to co-express human 
heme oxygenase-1 and ferritin. The E. coli were then grown with varying amounts of 
hemin to see if the iron released upon degradation of the hemin by heme oxygenase-1 is 
loaded into ferritin. Following incubation, the ferritin was purified and the amount of 
iron loaded into ferritin determined. It was found that ferritin purifed from E. coli 
expressing human heme oxygenase-1 contained more iron than E. coli that did not 
contain human heme oxygenase-1. It was concluded that some of the iron released upon 
degradation of hemin by heme oxygenase-1 can be sequestered by ferritin. 
INTRODUCTION 
Recent research has shown that reactive oxygen species (ROS), such as the 
hydroxyl radical or superoxide, can be the causation of various diseases [ 1]. The 
presence of free iron in cellular environments is one source of ROS, which produces the 
hydroxyl radical according to the Fenton reaction: 
The hydroxyl radical formed then reacts with surrounding substances, damaging DNA, 
proteins, or other molecules. Although iron can catalyze the deleterious oxidation of 
lipids, DNA, proteins, and other biomolecules [2], it is essential for various biochemical 
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processes. From oxygen carriers to electron transport chain proteins , iron plays many 
roles essential for life. While the Food and Drug Administration suggests that 18 
milligrams of iron should be consumed daily in order to replenish the body's iron, many 
people (approximately 500 million around the globe) suffer from iron deficiency [3,4]. 
Conversely, if iron is consumed in excessive amounts, iron concentration rises to toxic 
levels , a condition called hemochromatosis [3,5,6] . Both conditions can prove fatal. 
Hence, the uptake, use, and metabolism of iron must be tightly regulated to curb its 
potentially deleterious biological effects. 
Iron Uptake 
Iron is one of the most abundant elements in the earth's crust. It is widely used 
both in organic and inorganic processes. One of the biggest problems facing cells when 
trying to uptake iron is the relative insolubility of ferric hydroxide and other compounds 
from which iron must be extracted for use . The solubility product of ferric hydroxide is 
2. 79x 10-39 [7]. The aqueous environment of the cytosol is an inhospitable host for iron 
extraction from insoluable iron compounds . Of the 18 mg of iron consumed daily, only 
about one milligram is usually absorbed [8]. This generally is enough to compensate for 
the small loses of iron from the body, principally in the bile. However, the rate of iron 
uptake is not static, but varies according to the needs of the body. Iron uptake is greatly 
increased in pregnant and menstruating women [8]. Ascorbic acid, or Vitamin C, 
increases iron uptake, as does ingestion of meat [8]. The rate is variable and usually 
functions, although not perfectly, to maintain the iron balance in the body . 
The combination of the hydrophobic plasma membrane and the relative 
insolubility of iron creates a physiochemical barrier for intracellular iron uptake. In order 
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to overcome this barrier, iron is chelated and transferred from one organic ligand to 
another, thus minimizing the amount of free intracellular iron. This process differs in 
prokaryotic and eukaryotic cells. The uptake of iron by the human body is not fully 
understood [9-11 ], but is thought to resembles the uptake of iron by the yeast, 
Saccharomyces cervisiae [ 12] 
S. cervisiae has two systems for uptake of iron: a low-affinity system and a high-
affinity system [13,14]. The low-affinity system depends on cytoplasmic membrane 
proteins encoded by genes FETJ, FET2, and FET4 [11-13]. The FETJ and FET2 genes 
encode for different reductase proteins and FET4 encodes for a protein transporter. It 
seems that these three proteins work together, along with Fet3 copper oxidoreductase , to 
transport ferrous iron across the plasma membrane, and in the process , oxidizing it to 
ferric iron . The high-affinity uptake system is more complicated. It involves Fet3 copper 
oxidoreductase and a perm ease encoded by FTR 1 [ 14-17]. The complete mechanism is 
still unknown and is being actively researched. It is known, however , that a divalent 
cation transporter , which is coupled to the membrane proton gradient in the intestinal 
mucosa, is involved in iron uptake [ 18, 19]. 
In order for an increased rate in iron absorption, iron is generally reduced to 
ferrous iron [20]. Ferrous iron is absorbed more rapidly than ferric iron [20]. Once 
absorbed, iron may be quickly sequestered by transferrin, an iron carrying protein , in the 
intestinal mucosa! cells [3] , thus eliminating any possible free iron. In order for the iron 
to bind to transferrin , the iron must be reoxidized to ferric iron and chelated into an 
"unreactive" complex [3]. The chelated iron is then transferred to other proteins, such as 
blood plasma transferrin, and transported throughout the body in a safer, less toxic form . 
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Although the ultimate source of iron is the diet, 9 billion red blood cells are 
destroyed daily, yielding 20-25 mg of iron. Most of the iron is either recycled for use in 
various biochemical processes or stored [8]. 
Iron Storage 
Not all iron present in the body is used at the same time . A large portion of the 
iron is sequestered and stored for later use. A large globular protein called ferritin is the 
main storage protein for iron . Ferritin consists of an outer protein coat made of 24 
subunits. Each subunit forms a four-helix bundle motif. In human ferritin, there are two 
different subunits : light chain ferritin (molecular weight = 19 kDa) and heavy chain 
ferritin (molecular weight = 21 kDa). The twenty-four subunits form a cubic array with 
an empty core [21]. Inside this core is where the iron is stored . The exact mechanism of 
iron loading into ferritin is still under investigation . 
Two mechani sms for iron loading have been proposed . The most widely accepted 
hypothesis is that initially, a physiological transfer of iron from transferrin to ferritin 
occurs in which ferric iron is reduced to ferrous iron. The mechanism for this redox 
reaction is still unknown. It is thought that a diffusible cytoplasmic protein catalyzes this 
reaction . Once the iron has been reduced to ferrous iron and presented to the ferritin, it 
has been suggested the iron is reoxidized by molecular oxygen to ferric iron for 
deposition of iron in the core. This reoxidation is said to be catalyzed by the ferritin's 
intrinsic ferroxidase activity present in the centers of helical bundles of the heavy chains 
[22-26]. The proposed reaction for this process is: 
5 
The biggest problem with this proposed mechanism is that hydrogen peroxide is formed . 
As noted earlier , iron can catalyze the decomposition of hydrogen peroxide, producing 
the hydroxyl radical, which will react with the first organic molecule it contacts , which 
will most likely be the ferritin ferroxidase centers. This will lead to the eventual damage 
or inactivation of the ferroxidase centers and the ferritin may lose its ability to properly 
load and store iron. The second hypothesis for iron loading suggests that a cytoplasmic 
blue-copper oxidase protein , called ceruloplasmin, catalyzes the oxidation of Fe(II) to 
Fe(III), followed by deposition of the iron in the ferritin core. The proposed reaction for 
this process is : 
4 Fe2+ + 0 2 + 4H+ ➔ 4Fe 3+ + 2H20 
This mechanism presents iron to the ferritin in such a way as to not produce ROS [27), 
thus eliminating the possibility of damaging the ferritin. It has been shown that in saline 
solution at physiological pH, iron presented to apoferritin in the absence of ceruloplasmin 
was not incorporated into the core [28) . 
Ferritin is not the only iron storage molecule . Hemosiderin , a protein that seems 
to consist of ferritin partially degraded by lysosomes, also stores iron. It stores more iron 
than ferritin [8). If too much iron is absorbed from the diet, deposits of hemosiderin can 




Figure 1: Iron Protoporphrin IX (Heme) found in b-type cytochromes. 
Iron Usage 
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Iron is used in many different proteins throughout the body . The most well 
known protein is hemoglobin, the four-subunit blood oxygen carrier. Myoglobin, which 
only contains one subunit, is a similar protein that transports and stores oxygen in the 
muscle . Each of these proteins contain iron bound in a porphryin ring system. This 
porphryin-iron ring complex is known as heme (Figure 1 ). Heme is found in all 
organisms except anaerobic Clostridia and lactic acid bacteria, and can have both 
beneficial and deleterious effects [29]. In humans, there are many heme-containing 
proteins including hemoglobin and myoglobin. Hemoglobin and myoglobin are not the 
only heme containing proteins. Other proteins that include a heme group include, but are 
not limited to, nitric oxide synthase, cyclooxygenase, and various cytochromes [29]. 
The details of the process by which iron is incorporated into protoporphryin IX, 
the porphryin ring used to produce heme, are not known. It is evident, however, that the 
enzyme ferrochelatase catalyzes the transfer of free ferrous iron into the ring [30]. 
Another mechanism of iron incorporation also includes the oxidation of ferrous to ferric 
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iron by ceruloplasmin and be incorporated into heme by direct transfer from ferritin [31]. 
The study of heme production using recombinant human proteins in E. coli, for 
incorporation of iron into protoporphryin IX has not been successful. Research is 
currently being done to determine other enzymes that may be needed to assist in this 
process . It has been shown that there is a docking site between the proteins 
ferrochelatase and frataxin [32]. It is thought that frataxin serves as an iron chaperone to 
aid in the insertion of iron into heme. 
Heme is not the only form of ''usable" iron in the body. Iron also is used in iron-
sulfur proteins . This large family of proteins includes proteins such as ferredoxins, 
rubredoxins, and Rieske iron-sulfur proteins [33-35]. The most simple iron-sulfur 
complex is the rubredoxin complex. This complex contains iron but no inorganic sulfur. 
Iron is covalently attached in a distorted tetrahedron to four cysteine residues. Another 
type of iron-sulfur complex is the 2Fe-2S complex, in which 2 iron atoms are each 
covalently attached to two cysteine residues and are linked together through bonds to two 
inorganic sulfur atoms. There are also 4Fe-4S complexes. These complexes are usually 
used in electron transport reactions. Rieske iron-sulfur proteins are similar in structure . 
The main difference between them and regular iron-sulfur complexes is that one of the 
iron atoms is coordinated to 2 histidine residues rather that 2 cysteine residues. This 
complex is important in the cytochrome bc 1 complex (complex III) of the mitochondrial 
electron transport chain [36]. 
When complexed into the right proteins, iron plays very crucial roles. However , 
the proteins wear out with use. When worn out, the proteins are degraded . In the case of 
hemoglobin, the protein enters a proteosome and is digested into smaller peptide chains 
and individual amino acids. The proteosome, however, cannot degrade the heme 
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compontent and releases it to the cytoplasm. Free heme is dangerous to cells because it 
induces oxidative stress and greatly increases cellular death [1]. 
Heme Metabolism 
In order to cope with excess heme, a metabolic pathway evolved that provides for 
the enzymatic breakdown of heme. The central enzyme of this heme metabolism 
pathway is heme oxygenase-1 (HO-1) [37]. Human HO-1 is a mitochondrial-membrane 
bound protein that catalyzes the NADPH- and cytochrome P450 reductase-dependent 
oxidation and breakdown of heme into carbon monoxide, biliverdin, and ferric iron [37]. 
The biliverdin produced is then reduced to bilirubin by biliverdin reductase , which is 
conjugated for secretion [38]. 
Heme metabolism by heme oxygenase does eliminate heme, however it releases 
ferrous iron , which can participate in further deleterious oxidations . This redox-active 
iron must be removed from the cytoplasm in order to prevent such oxidations . Ferritin , a 
protein with a very high capacity for storing iron [39], could be the protein that sequesters 
this free iron. Recent research has shown that the up-regulation of heme oxygenase and 
ferritin in endothelial cells is effecti ve in the protection of endothelium against the 
damaging effects of exogenous heme and other oxidants [ 1]. The mechanism behind this 
phenomenon has not been explained , however. 
The hypothesis of this study is that iron released from heme degradation by HO-1 
is loaded into ferritin , thus limiting the potential deleterious effects of free iron . In order 
to test the hypothesis, the genes encoding for human HO-1 and ferritin were 
simultaneously expressed in Escherichia coli strain B834. The strain was then exposed 
to varying amounts of hemin. Following incubation for 24-36 hours, the ferritin was 
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purified . The amount of iron loaded into ferritin was determined by a modified version 
of the reductive release assay determined by Thomas et al. [ 40], utilizing paraquat and 
bathophenanthroline. If the hypothesis for this study is correct, it should be observed that 
as the concentration of hemin is increased, more iron should be loaded into ferritin . 
MATERIALS 
The heme oxygenase-1 gene, obtained from Dr. Paul R . Ortiz de Montellano 
(University of California) , was inserted into pCDFDuet-1, purchased from Novagen. 
The plasmid containing a gene for ferritin H-chain homomer and the E. coli B834 cell 
line used for simultaneously expressing ferritin and heme oxygenase-1 were provided by 
Zane Davis (Utah State University). 
M9 minimal medium was prepared using M9 Minimal salts and other chemicals 
from Sigma. Hemin and chemicals used in ferritin unloading assay were purchased from 
Sigma. 
All water used was doubly deionized water. 
METHODS 
Bacterial Strains. E.coli strain XU-Blue was used for initial production of heme 
oxygenase-1 in pCDFDuet-1 and E. coli strain B843 for the dual expression of heme 
oxygenase-1 and ferritin. 
Construction of modified pCDFDuet-1. The gene encoding heme oxygenase-1 
was amplified by the polymerase chain reaction (PCR) from the pUC 18 plasmid provided 
by Paul Ortiz de Montellano. The 5 ' -sense oligonucleotide primer ( 5' -CGCGGA TCCA 
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dNTPs 1 0.2mM of each 
10xBuffer 5 1X 
MgCl2 3 1.SmM 
Template 1 1 µg/50µI 
Forward 
primer 1 0.2µM 
Reverse 
primer 1 0.2µM 
Taq DNA 
Polymerase 1 5 units 
Table 1: PCR Conditions for Amplification of the gene encoding HO- I. 
GAGCGTCCGCAAC-3 ') encoded for the BamHI restriction site. The 3 '-antisense 
oligonucleotide pnmer (5'-CCCAAGCTTTTAAGCCTGGGAGCGG-3') encoded the 
tennination codon for a truncated form of HO-1 ending at proline 23 amino acids from 
the C-terminus immediately preceding a HindIII site. The sequence encoding the 
remaining 23 amino acids was not included because they form a signal sequence that 
directs human heme oxygenase-1 to the mitochondria , which is not needed in this case. 
PCR was perfonn ed using a Perkins Elm er PCR amplification 9600 Thermocycl er 
System. The reaction mixture was according to concentrations given in Table 1. The 
cycle consisted of an initial melting cycle of two minutes at 95°C followed by 30 cycles 
of denaturation , annealing , and extension , followed by a final ten minute extension . 
Denaturation was performed at 95°C for one minute, annealing at 55°C for one minute, 
and extension at 74° C for two minutes (or ten in the last step). The PCR product was 
purified using the QIAquick PCR Purification kit (Qiagen) and analyzed by agarose gel 
electrophoresis for purity (Figure 2). 
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Figure 2: Ethidium bromide agarose gel electrophoresis of the gene H0-1 . The gene H0-1 was 
amplified using PCR and analyzed by agaro se gel electrophore sis after staining by ethidium bromide . The 
first column is the H0 -1 gene and the second column is the Fermentas 1kb Gene Ladder. 
The pCDFDuet-1 plasmid and gene insert were sequentially digested , first with 
BamHl , followed by Hindlll. The initial digestion contained 4 µg of DNA , 10 units * of 
BamHI , 2 µl of BamHI Buffer (Fermentus) , and water , for a final reaction volume of 20 
µI. The solution was incubated at 37° C for 2 hours and product purified using QIAquick 
PCR Purification kit. A second digestion was performed using the total product obtained 
from the previous step (approx . 2 µg DNA in 30 µl of storage buffer) , 10 units of HindIII , 
4 µl of Buffer R (Fennentus) , and water, for a final reaction volume of 40 µI. Analysis 
by agarose gel electrophoresis of pCDFDuet-1 digested with a single enzyme revealed 
that both Hindlll and BamHI were successful at cutting the plasmid . 
Ligation of the insert into the digested pCDFDuet-1 plasmid was performed at 1 :4 
and 1 :6 plasmid-to-insert concentrations , using 100 ng of digested pCDFDuet-1 in each 
ligation mixture. The 1 :4 reaction contained 180 ng of digested gene insert and 1 :6 
contained 240 ng. A negative control contained no gene insert. Each reaction mixture 
• 1 unit defined as the amount of enzyme required to completely digest 1 µg of substrate DNA in a 50 µI 
reaction in 60 minutes. 
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contained 2.5 unit st of T4DNA ligase. Reactions were incubated at 16° C overnight 
(about 16 hours). T4DNA ligase was then denatured by incubating the reaction mixtures 
at 65° C for 10 minutes. 
Ligation products were directly used for transformation . Transformation using E. 
coli strain XLl-Blue was performed as outlined by Stratagene for XLl-Blue 
Supercompetent Cells . Four separate transformations were performed, each containing 
100 µl of XLl-Blue cells. Each was incubated on ice with 1.7 µl of ~-mercaptoethanol 
for IO minutes. Following incubation , 3 µl of each ligation reaction was added to three of 
the transformation mixtures . To the fourth was added 50 ng of undigested pCDFDuet-1 
to act as a positive control. The transformation mixtures were then incubated on ice for 
30 minutes , followed by a heat shock step at 42° C for 30 seconds. The mixtures were 
then incubated on ice for an additional 2 minutes . Following incubation , 500 µl of SOC 
medium heated to 42° C was added to each transformation mixture, followed by 
additional incubation in a rotating shaker at 37° C at 225-250 rpm for 45 minutes. 
Following incubation , 100 µl of each transformation volume was plated separately on 
agar plates containing streptomycin and incubated for 24 hours at 37° C. 
Colonies were harvested from the 1 :6 dilution plate and grown in 3 ml of LB 
medium containing streptomycin. Following incubation for 10 hours, 1 ml was used to 
analy ze for successful ligation and transformation . Plasmid DNA was purified using 
Multipore Purification System and analyzed via PCR for incorporation of HO-1 gene. 
Further confirmation of gene incorporation was obtained by DNA sequencing . Colonies 
showing successful incorporation of HO-1 were then grown in 100 ml cultures and their 
plasmid DNA purified. 
t 1 unit of enzyme catalyzes the incorporation of IO nmoles of deoxyribonucleotides into a polynucleotide 
in 30min at 70°C. 
13 
Simultaneous Expression of H0-1 andferritin in E. coli. The plasmid containing 
the gene for HO-1 was transformed into a B834 strain already containing the gene 
encoding ferritin H-chain homomer according to the procedure given previously for 
transformation into XLl-Blue cells. Transformed cells were plated on agar plates 
containing ampicillin, streptomycin, and chloramphenicol and incubated at 37° C for 24 
hours. All colonies that grew were cultured and analyzed for incorporation of both 
ferritin and H 0-1 genes using PCR. 
LB medium containing ampicillin, streptomycin, and chloramphenicol was 
inoculated with cells containing both ferritin and HO-1 genes. Cultures were incubated 
for about 8 hours at 37° C while shaking at 225 rpm. Ten milliliters were then removed 
and spun at 7100 rpm (6000 x g) in a Sorval SS-34 rotor at 4° C for 20 minutes. The 
supernatant was decanted and cells resuspended in 5 ml of M9 medium containing 
ampicillin, streptomycin , and chloramphenicol. Larger cultures of M9 medium (500 ml) 
were inoculated with this suspension and incubated at 37° C while shaking at 180 rpm 
until they reached an absorbance A600= ~0.8. Each culture was then induced by addition 
of 0.119 g of isopropylthiogalactopyranoside (IPTG) . Incubation was continued for six 
more hours. Some cells from each culture were removed, lysed, and ran on SDS-PAGE 
to check for production of both ferritin and HO-1. 
Degradation of Hemin. Four cultures were grown in M9 medium as described 
above . Three cultures contained the B834s with both HO-1 and ferritin genes. The 
fourth culture only had ferritin to serve as a control. Hemin, dissolved in 1 ml of 1 M 
NaOH, was added to the four cultures according to Table 2. Each culture was incubated 
for another 24 to 36 hours at 37°C while shaking at 180 rpm. 





HO-1 & Ferritin 
HO-1 & Ferritin 
HO-1 & Ferritin 
Ferri tin 





Table 2: Addition of Hemin. Three cultures and a control were incubated with differing amount s of 
hemin to test for the incorporation of iron into ferritin . 
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Purification of Ferritin. Cells from each culture were harvested by centrifugation 
for 12 minutes at 5500 rpm (5000 x g) at 4° C using a GS-3 rotor. Cells were 
resuspended m 5 ml of Lysis Buffer (DNase at l0µg/ml , RNase at l0µg/ml, and 
lysozyme at lmg/ml in 50 ml of 50mM Tris, pH 7.0). The cells were then lysed by 
freezing in liquid N2 followed by subsequent thawing in a 42° C water bath . This 
freeze/thaw process was repeated three times to ensure complete lysis . The lysed cells 
were then centrifuged at 10,000 x g (9,000 rpm) for 20 minutes using a SS-34 rotor in a 
Sorval RC-3B centrifuge to remove unwanted cellular debris . The supernatant was 
decanted and recentrifuged at 43,000 x g (19,000 rpm) for 20 minutes using a SS-34 
rotor . The supernatant was saved and pellet discarded. The supernatant was then added 
to a pre-equilibrated t DEAE-Sepharose column. The column was sequentially washed 
according to the sequence in Table 3 and fractions from each wash collected . Protein-
rich fractions were identified using SDS-P AGE and pooled. The pooled fractions were 
then concentrated to 1 ml using a YM-100 filter membrane (100 kDa molecular weight 
cut-off) . The concentrated solution was then heat-treated at 65° C for 15 minutes in a 
t Pre-equilibrated with I bed volume of 1 N NaOH, I bed volume of2 N NaCl at pH 7.0, and 6 bed 
volumes of 50 mM Tris at pH 7 .0. 
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DEAE Column Elution 
Eluate 1 bed volume at pH 7.0 
50 mM Tris 
2 50 mM NaCl/50 mM Tris 
3 100 mM NaCl /50 mM Tris 
4 150 mM NaCl/50 mM Tris 
5 200 mM NaCl/50 mM Tris 
6 2 M NaCl 
Table 3: Purification of Ferritin by DEAE-Sepharose anion exchange chromatography. The 
eluate from each step was analyzed by SDS-P AGE for the presence of ferritin. It was found that eluates 4 
and 5 contained the ferritin. 
water bath, followed by centrifugation at 5,000 x g (8,000 rpm) for 20 minutes in a table 
top centrifuge to remove denatured proteins . The supernatant was chromatographed over 
a Sepharose CL6B size exclusion column at 4° C using Chelex-100 (Sigma) treated 50 
mM NaCl (pH 7.0) at a flow rate of 0.3 ml per minute. A Bradford assay was done to 
identify protein-rich fractions , followed by SDS-PAGE to identify fractions containing 
pure ferritin [41] . These were pooled and concentrated to 1 ml and another Bradford 
assay performed to determine protein concentration . 
Determination of Iron Content. The amount of iron loaded into ferritin for each 
sample was determined using an iron unloading assay described by Thomas and Aust 
[ 40] with some modifications . This assay utilizes the iron chelator , bathophen-anthroline 
sulfonate (c=0.002214 µM· 1cm·1) , to quantitatively determine the amount of iron that is 
reductively released from ferritin. The assay was conducted in a 1 ml volume. To 
conduct the assay, a mixture of 0.25 mM paraquat , 1.0 mM bathophenanthroline 
sulfonate, 5 mM glucose in 50 mM NaCl was purged with argon for 5 minutes. Ferritin 
was then added (concentrations ranging from 20 to 40 ng), along with 0.1 units of P450 
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reductase, 10 units of glucose oxidase, and 500 units of catalase. This was then allowed 
to sit for 5 minutes to ensure that the incubation mixture was anaerobic. The reaction 
was started by adding NADPH (0.3 mM) to the mixture and taking a continuous 
absorbance using a Shimadzu UV-2101PC UV-VIS Scanning Spectrophotometer at 535 
nm. The maximum A535 was recorded for each run and concentration of iron-
bathophenanthroline determined by A= E 1 c, where 1 equals 1 cm, i::=0.002214 µM-1cm-1, 
and c is the concentration of reacted bathophenanthroline, which is directly proportional 
to the amount of iron released. The amount of iron released per ferritin molecule was 
then determined algebraically. 
RESULTS 
Construction of modified pCDFDuet-1 and simultaneous production of ferritin 
and HO-I . Successful incorporation of HO-1 into pCDFDuet-1 was verified using PCR 
and gene sequencing . When incubated in LB medium and induced by addition of IPTG, 
the medium turned green due to the accumulation of biliverdin. This is consistent with 
the results of Ortiz de Montellano in which he stated that E. coli "have a reductase 
activity capable of supporting the catalytic turnover of [HO-1]. [ 42]" 
When the modified pCDFDuet-1 was transformed into B834's already containing 
the gene for ferritin, one colony grew. The colony was harvested, cultured, and the 
presence of both genes was confirmed by PCR. 
Growth of the culture in M9 medium followed by induction by IPTG addition did 
not lead to a change in color, as it did LB medium. However, SDS-PAGE revealed that 
both proteins were produced. 
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Figure 3: Total Iron Assay for Iron in Ferritin. Ferritin was purified from bacteria grown on 
differing concentrations of hemin . Iron was released from ferritin by paraquat in the presence of 
bathophenanthroline . Absorbance of bathophenanthroline -iron complex was measured at 535nm. The 
concentration ofhemin in the media is as follows: b) 100 µM hemin, c) 50 µM hemin, d) 15 µM hemin , e) 
Negative Control (15 µM hemin , no HO-I gene). Trace a is th release of iron from control ferritin, loaded 
with iron in vitro. The data were obtained in triplicate but the data shown is from one assay . 
Degradation of Hemin. Hemin, a dark red brown solid, was dissolved in NaOH, 
and added to the samples as outlined 111 Table 4. Upon addition of 
the hemin, the cultures turned different shades of brown, the darker brown corresponding 
to the higher concentrations of hemin . Incubation of the cultures for 24 to 36 hours led to 
a slight change in color, with each culture containing H0-1 becoming more green. The 
control, which did not contain H0-1 , showed no noticeable color changes. 
Purification of Ferritin and Determination of Iron Loaded into Ferritin . Ferritin 
. 
was purified from each sample and the protein concentrations determined by the Bradford 
method [ 41]. The iron was released reductively from ferritin by the cation free radical of 
paraquat and the absorbance of bathophenanthroline-iron measured at 53 5 nm (Figure 3 ). 
Each sample, excluding the positive control, was analyzed in triplicate . Average iron 






Amount of Iron in Ferritin Determined by 
Reductive Release of Iron from Ferritin by 
The Cation Free Radicals of Paraquat 
Hemin cone . Iron 
(µM) (atoms Fe/Ferritin) 
15 2.9 (±0.3) 





Table 4: Iron content in from ferritin purified fom bacterial cells containing heme oxygenase-1 and grown 
on media containing hemin. The average amount of iron atoms unloaded per ferritin H-chain homomer 
was determined using the total iron content and the protein concentration of each sample. Each sample 
assay was performed in triplicate, except for the + control. The + control was a sample of loaded ferritin 
H-chain homomer. The data are reported as the average with standard deviation. 
DISCUSSION 
The results of this study indicate that iron released during the degradation of heme 
by heme oxygenase-1 is loaded into ferritin. As the concentration of heme increased in 
the medium, the amount of iron loaded into ferritin increased. This is especially evident 
when comparing Sample 1 with Control 1. Control 1 does not contain the human heme 
oxygenase-1 gene . Sample 1, which contained heme oxygenase-1, showed a 2.3-fold 
increase for iron loaded into ferritin. This increase suggests that the iron released 
following heme degradation is sequestered by the cell into ferritin in order to eliminate 
the potential deleterious effects of free iron. This cytoprotective mechanism explains 
why up-regulation of heme oxygenase-1 and ferritin has proven effective in shielding 
cells from deleterious effects of free heme [ 1]. The iron released by heme degradation is 
loaded into ferritin, thus limiting the potential deleterious effects of free iron. 
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